ArticleCureus2023
Unmasking the Enigma of the COVID Toe.
Article in Cureus, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 2 citations in OpenAlex.
- The Spectrum of Cutaneous Manifestations in Lupus Erythematosus: A Comprehensive Review.Journal of clinical medicine · 2024Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In 2020, the world encountered a new infection known as COVID-19. As a result, people started experiencing various COVID manifestations, aftereffects, and sequelae, one of which is the COVID toe, a rather uncommon presentation. Chilblain-like lesions, commonly referred to as 'COVID toe' due to their high occurrence on toes and fingers, can develop in any age group but are most commonly seen in younger adults. A 35-year-old female presented with painful pinkish-purple discoloration of her toes a week after acquiring a COVID-19 infection. Following this, she underwent blood tests and scans to rule out vasculitis and other autoimmune illnesses. The case highlights the distinctive presentation of this condition and its unusual appearance. This emphasizes that the COVID toe can vary from person to person, and not all cases are self-limiting. Depending on the presentation and the duration of symptoms, one may need to consider more extensive treatment, as not all cases resolve by themselves. This case report was presented as a poster at the Acute and General Medicine Conference in London, United Kingdom.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.